Data-Driven Decision-Making in Advanced Breast Cancer: HER2 and HER2-low Breast Cancer Updates

home / insights / data-driven-decision-making-in-advanced-breast-cancer-her2-and-her2-low-updates

Expert perspectives on the evolving treatment paradigm of HER2-expressing breast cancer and how learnings from recent clinical trials are impacting real-world practices.

Sara A. Hurvitz, MD, an expert on breast cancer

EP. 1: Overview on Treatment Options for HER2+ Breast Cancer

Aditya Bardia, MD, MPH;Sara A. Hurvitz, MD;Virginia Kaklamani, MD, DSc;Heather McArthur, MD, MPH;Shirley Michelle Shiller, DO
February 21st 2023
S. Michelle Shiller, DO, AP/CP, MGP, a molecular pathologist

EP. 2: Expert Perspectives on Defining HER2-Low Breast Cancer

Aditya Bardia, MD, MPH;Sara A. Hurvitz, MD;Virginia Kaklamani, MD, DSc;Heather McArthur, MD, MPH;Shirley Michelle Shiller, DO
February 21st 2023
Heather McArthur, MD, an expert on breast cancer

EP. 3: Optimizing Real-World Management of HER2-Low Breast Cancer

Aditya Bardia, MD, MPH;Sara A. Hurvitz, MD;Virginia Kaklamani, MD, DSc;Heather McArthur, MD, MPH;Shirley Michelle Shiller, DO
February 28th 2023
Sara A. Hurvitz, MD, an expert on breast cancer

EP. 4: Potential Role for T-DXd in Early-Stage HER2-Low Breast Cancer

Aditya Bardia, MD, MPH;Sara A. Hurvitz, MD;Virginia Kaklamani, MD, DSc;Heather McArthur, MD, MPH;Shirley Michelle Shiller, DO
February 28th 2023
Virginia Kaklamani, MD, an expert on breast cancer

EP. 5: Advice for Community Physicians on Managing HER2+ Breast Cancer

Aditya Bardia, MD, MPH;Sara A. Hurvitz, MD;Virginia Kaklamani, MD, DSc;Heather McArthur, MD, MPH;Shirley Michelle Shiller, DO
March 7th 2023